LIVE #WCLC26 — live KOL coverage of the World Conference on Lung Cancer View Full Coverage →
KOL Pulse AI · WCLC26 Pre-Work Series · Conference Intelligence
WCLC26 Pre-Work: Virtual Attendee Network
Pre-conference snapshot, data through September 8, 2026. 484 accounts classified from 419 curated posts ahead of WCLC 2026. Use it to plan the week: click any of the top 20 KOLs to see exactly who amplified them - by category, region and country - and use the trial section to find the physicians already engaged with each readout. The classification separates physicians, patient advocates and advocacy organizations, conference organizations, industry, and media. Pairs with the Pre-Work influencer network for who drives and who amplifies the conversation.
434 Identified Accounts 60 Verified US Physicians 124 Int'l Physicians 32 Countries
Interactive Retweeter Analysis
Click any KOL below to explore their retweeter network
See who amplified each top voice — broken down by category, region, and country. The donut charts and Top 30 grid update in real time as you switch KOLs.
Top 20 KOLs ranked by total impressions
Category Breakdown
All Physicians by Region
Top Accounts
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • Enhanced KOL profiles
  • Pharma influence & potential advisory-board patterns
  • 2025 Open Payments financial analysis
  • Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.
Trial Interest
Which Trials Are Physicians Engaged With Before Seoul?
Physicians whose pre-conference posts or shared slides reference each readout - the conversations already forming before the data drops.
MAVERICK9 physiciansHidehito HORINOUCHI · gilberto lopes · Drew Moghanaki · Masahiro TORASAWA · Uğur Özkerim · Laura Alder · Dr. Nagla Abdel Karim · Dr. Estela Rodriguez +1 more
PAPILLON9 physiciansHidehito HORINOUCHI · gilberto lopes · Masahiro TORASAWA · Uğur Özkerim · Laura Alder · Dr Riyaz Shah · Dr. Estela Rodriguez · Tom Newsom-Davis +1 more
REZILIENT39 physiciansHidehito HORINOUCHI · gilberto lopes · Masahiro TORASAWA · Uğur Özkerim · Laura Alder · Dr Riyaz Shah · Dr. Estela Rodriguez · Tom Newsom-Davis +1 more
ARROS-18 physiciansHidehito HORINOUCHI · gilberto lopes · Masahiro TORASAWA · Uğur Özkerim · Laura Alder · Dr Riyaz Shah · Dr. Estela Rodriguez · Aakash Desai
ARTEMIS-0088 physiciansHidehito HORINOUCHI · gilberto lopes · Masahiro TORASAWA · Uğur Özkerim · Laura Alder · Dr Riyaz Shah · Dr. Estela Rodriguez · Aakash Desai
EVOKE-038 physiciansHidehito HORINOUCHI · gilberto lopes · Masahiro TORASAWA · Giannis Mountzios · Uğur Özkerim · Laura Alder · Dr. Estela Rodriguez · Aakash Desai
TAISHAN-3028 physiciansHidehito HORINOUCHI · gilberto lopes · Masahiro TORASAWA · Uğur Özkerim · Laura Alder · Dr Riyaz Shah · Dr. Estela Rodriguez · Aakash Desai
ADAURA7 physiciansHidehito HORINOUCHI · gilberto lopes · Masahiro TORASAWA · Uğur Özkerim · Laura Alder · Dr Riyaz Shah · Dr. Estela Rodriguez
DESTINY-Lung045 physiciansHidehito HORINOUCHI · gilberto lopes · Dr Riyaz Shah · Dr. Estela Rodriguez · Aakash Desai
DeLLphi-3094 physiciansHidehito HORINOUCHI · Laura Alder · Dr. Estela Rodriguez · Eric K. Singhi
Understanding This Report
Questions This Pre-Work Report Answers

What does this data show?

A verified, classified map of the pre-conference conversation: 485 accounts from curated posts, including 184 physicians — 60 US physicians and 124 international colleagues from 29 countries (UK, India, Japan and France lead). Institutional clusters are visible before the meeting starts: Sylvester Comprehensive Cancer Center (4), MD Anderson Cancer Center (4), Mayo Clinic (3), Memorial Sloan Kettering (3). Trial interest concentrates around MAVERICK (9 physicians), PAPILLON (9 physicians), REZILIENT3 (9 physicians). 31 patient advocates and advocacy organizations are active in the same conversation — and the bot and persona accounts that inflate raw follower metrics were identified and quarantined, so every physician here is bio-verified.

How can a KOL learn from this report?

Benchmark your own pre-meeting presence against the 184 physicians mapped here: are your trials of interest among the crowded conversations (MAVERICK, PAPILLON, REZILIENT3) or the quiet ones where a single voice still stands out? The category and region breakdowns show which patient advocacy voices and international colleagues are already active in your space, and the trial section names the physicians - with their institutions - engaged with each readout, colleagues worth connecting with in Seoul.

What does a worked example of using this data look like?

An MSL preparing for Seoul: Sylvester Comprehensive Cancer Center alone has 4+ physicians in the pre-meeting conversation. Cross-reference the trial section — MAVERICK (9 physicians), PAPILLON (9 physicians), REZILIENT3 (9 physicians) are the crowded conversations — and the briefing plan writes itself: which physicians at which institutions are already engaged with which readouts, before a single meeting is booked. A KOL can run the same play in reverse: find your institution's cluster, see which trials your colleagues are converging on, and position your own commentary where the map shows white space.

How can medical affairs and pharma teams use this report?

As pre-meeting territory planning grounded in this page's own numbers: the category and region breakdowns surface the 60 verified US physicians and their international colleagues, each with institution and trial interests; the classification keeps engagement lists clean by separating treating physicians from the 57 media accounts and industry voices; and the trial-interest chips let field teams match MSL briefings to the readouts a physician already follows. KOL identification tells you who matters; mapping tells you how the community organizes around institutions and trials — which is what engagement sequencing actually needs. Influence-mapping practice guides note this also reduces redundant outreach: teams see who is already saturated and who is unengaged.

Why is social influence mapping important in oncology?

Oncology standards change with each congress readout, and physicians increasingly learn about readouts from each other online — surveys report over 70% of HCPs use digital channels weekly for medical information, and in a LiveWorld–Sermo survey of 206 US physicians, 41% said social media influences prescribing behavior. A pre-conference map matters most because congress weeks are when oncology opinion actually forms: this dataset shows the communities already organized before the first presentation — Sylvester Comprehensive Cancer Center (4) and MD Anderson Cancer Center clusters, 31 active patient advocacy organizations, and MAVERICK-focused physician groups.

What is the difference between a KOL and a Digital Opinion Leader?

A traditional KOL earns influence through trials, publications, and guideline work; a Digital Opinion Leader earns it through digital reach — posts, threads, podcasts, and amplification. Many physicians on this page are both: trial investigators whose conference posts reach tens of thousands. This report measures the digital half directly and pairs it with verified identity, institution, and trial interests so the two kinds of influence can be read together.

How can I use this report with my favorite AI tool?

This page is built to be read by AI assistants (ChatGPT, Gemini, Claude, Perplexity). Paste the URL into your tool and ask questions this page can actually answer: “Which institutions have the most physicians in the WCLC 2026 pre-conference conversation?”, “Which trials are pre-meeting physicians most engaged with?”, “Which physicians are engaged with MAVERICK before the meeting?”, “List the patient advocacy organizations active before WCLC 2026.” For who-influences-whom questions (a KOL’s amplifier network, which US physicians amplify a given voice), use the companion Pre-Work influencer network. Cite kolpulse.com when you share the answers.